Page last updated: 2024-08-25

zoledronic acid and Jaw Diseases

zoledronic acid has been researched along with Jaw Diseases in 143 studies

Research

Studies (143)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	89 (62.24)	29.6817
2010's	51 (35.66)	24.3611
2020's	3 (2.10)	2.80

Authors

Authors	Studies
Huo, L; Li, JW; Wang, JY; Yu, RQ; Zheng, LW	1
Arce, RM; Auersvald, CM; Awad, ME; Celis, E; Cutler, CW; Elashiry, M; Eldin M Elshikh, M; Elsalanty, ME; Elsayed, R; Gerber, J; Isales, C; Kurago, Z; Meghil, M; Sultan, H; Sun, C; Zeitoun, R	1
Halling, F; Lux, C; Otto, M; Schlittenbauer, T; Ziebart, T	1
Hirasawa, N; Imatoh, T; Sai, K; Saito, Y; Segawa, K; Takeyama, M	1
Beth-Tasdogan, NH; Hussein, H; Mayer, B; Zolk, O	1
Estilo, CL; Huryn, JM; Liang, STY; Owosho, AA; Sax, AZ; Wu, K; Yom, SK	1
Çankaya, M; Dayisoylu, EH; Ersöz, S; Şenel, FÇ; Taskesen, F; Tosun, E; Üngör, C	1
Shapiro, CL	1
Agrawal, R; Bell, R; Brown, JE; Cameron, D; Chakraborti, P; Coleman, RE; Collinson, M; Jyothirmayi, R; Liversedge, V; Marshall, HC; Murden, GA; Rathbone, EJ; Spensley, S; Yuille, F	1
Gerngroß, C; Hahnefeld, L; Hohlweg-Majert, B; Jansen, H; Kehl, V; Koerdt, S; Otto, S; Pautke, C; Ristow, O; Schwaiger, M	1
Felsenberg, D; Gabbert, TI; Hoffmeister, B	1
Cha, IH; Kim, JW; Kim, MR; Kim, SJ; Landayan, ME; Lee, JY; Tatad, JC	1
Gallego, L; Junquera, L	1
Andreadis, C; Boukovinas, I; Koloutsos, G; Kyrgidis, A; Patrikidou, A; Teleioudis, Z; Triaridis, S; Vahtsevanos, K	1
Al-Nawas, B; Beck, J; Gamm, H; Grötz, KA; Thomas, C; Thüroff, JW; Wagner, W; Walter, C; Zinser, V	1
Cheng, JC; Wong, YK	1
Ascani, L; Bareggi, C; Brunelli, C; Campa, T; Cislaghi, E; Fagnoni, E; Maniezzo, M; Ripamonti, CI; Saibene, G	1
Bareggi, C; Bianchi, C; Borgonovo, K; Cobelli, S; Farina, G; Garassino, M; La Verde, N; Mantica, C; Mihali, D; Pedretti, D; Perrone, S; Rizzo, A; Sburlati, P	1
Bamia, C; Bamias, A; Christoulas, D; Dimopoulos, MA; Eleftherakis-Papaiakovou, E; Gika, D; Kastritis, E; Melakopoulos, I; Migkou, M; Roussou, M; Terpos, E	1
Anderson, KC; Lerman, MA; Lyng, GD; Sonis, ST; Watkins, BA	1
Kyrgidis, A; Teleioudis, Z; Vahtsevanos, K	1
Abati, S; Carmagnola, D; Celestino, S	1
Berruti, A; Fusco, V; Ortega, C	1
Badros, A; Chaisuparat, R; Cullen, KJ; Meiller, TF; Scheper, MA	1
Kyrgidis, A; Triaridis, S	1
Andreadis, C; Kyrgidis, A	1
Frerich, B; Hemprich, A; Kluge, R; Sabri, O; Schulz, T; Steinhoff, K; Wilde, F; Winter, K	1
Chantrain, G; Decaestecker, C; Hupin, C; Javadian, R; Loeb, I; Magremanne, M; Saussez, S	1
Ayllon, J; Cros, C; Launay-Vacher, V; Medioni, J; Oudard, S; Spano, JP	1
Biasotto, M; Chiandussi, S; De Nardi, E; Di Lenarda, R; Dore, F; Tirelli, G	1
Kressley, A; Saif, MW; Smith, A	1
Elad, S; Hardan, I; Lazarovici, TS; Taicher, S; Yahalom, R; Yarom, N	1
Balasanian, E; Stanton, DC	1
Fenner, M; Hinkmann, FM; Lell, MM; Neukam, FW; Nkenke, E; Stockmann, P; Vairaktaris, E	1
Baer, D; Han, MM; Hui, RL; Khoury, S; Liao, W; Liberty, D; Lo, JC; Martin, D; O'Ryan, FS	1
Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A	1
Andreadis, CG; Antoniades, K; Boukovinas, I; Katodritou, E; Kitikidou, K; Koloutsos, GE; Kyrgidis, A; Paraskevopoulos, P; Teleioudis, Z; Triaridis, S; Vahtsevanos, K; Verrou, E; Zervas, K	1
Castellana, MA; Gasparini, G; Longo, R	1
Hata, K; Hiraga, T; Kobayashi, Y; Matsumoto-Nakano, M; Ueda, A; Wang, L; Yatani, H; Yoneda, T	1
Crawford, BS; Kraut, EH; McNulty, RM; Turowski, RC	1
Divgi, C; Grewal, RK; Hudis, CA; Larson, S; Mak, AF; Modi, S; Morris, PG; Patil, S; Poznak, CV	1
Fossion, E; Huizing, MT; Van den Wyngaert, T; Vermorken, JB	1
Adams, JS; Christensen, R; Chung, EM; Felsenfeld, AL; Garrett, N; Hokugo, A; Nishimura, I; Sayre, JW; Sung, EC	1
Akiyama, K; Chen, C; Chen, W; Kikuiri, T; Kim, I; Le, AD; Li, Y; Shi, S; Wang, S; Yamaza, T; Zhang, Q	1
Biasotto, M; Cavalli, F; Chiandussi, S; Contardo, L; Di Lenarda, R; Dore, F; Giacca, M; Moimas, S; Pozzato, G; Zacchigna, S; Zanconati, F	1
Arduino, PG; Broccoletti, R; Dalmasso, P; Mozzati, M; Scoletta, M	1
Allen, MR; Burr, DB; Chu, TM; Kubek, DJ; Ruggiero, SL	1
Bi, Y; Cao, C; Ehirchiou, D; Gao, Y; Kikuiri, T; Le, A; Shi, S; Zhang, L	1
Beninati, F; Ficarra, G	1
Lurie, R; Meer, S; Suleman, YF	1
Bauss, F; Drosse, I; Ehrenfeld, M; Opelz, C; Otto, S; Pautke, C; Schieker, M; Schwager, J; Westphal, I	1
Bauer, F; Ehrenfeld, M; Hafner, S; Hohlweg-Majert, B; Kolk, A; Kreutzer, K; Mast, G; Otto, S; Pautke, C; Steiner, T; Stürzenbaum, SR; Tischer, T; Weitz, J; Wolff, KD	1
Black, DM; Bucci-Rechtweg, C; Grbic, JT; Lyles, KW; McClung, M; Orwoll, E; Reid, DM; Su, G	1
Acham, S; Jakse, N; Obermayer-Pietsch, B; Rugani, P; Truschnegg, A	1
Berenson, JR; Bolejack, V; Crowley, J; Farber, CM; Flinn, IW; Gravenor, DS; Hilger, JD; Makary, A; Morganstein, N; Nassir, Y; Sanani, S; Sefaradi, A; Shamouelian, A; Staszewski, H; Swift, RA; Tiffany, NM; Upadhyaya, GH; Yang, HH; Yellin, O	1
Liu, Y; Ning, J; Ravosa, MJ; Stack, MS	1
Pazianas, M	1
Brandi, ML; Cavalli, L; Cavalli, T; Falchetti, A; Marini, F; Masi, L; Tonelli, P	1
Díaz-Bobes, C; Gallego, L; Junquera, L; Pelaz, A	1
Arduino, PG; Battaglio, C; Berardi, D; Broccoletti, R; Chiecchio, A; Donadio, M; Gandolfo, S; Menegatti, E; Mozzati, M; Scoletta, M; Scully, C; Vandone, AM	1
Campisi, G; Colella, G; Favia, G; Fusco, V; Gabriele, M; Gaeta, GM; Manfredi, M; Mergoni, G; Merigo, E; Peluso, F; Solazzo, L; Vescovi, P	1
Ferlito, S; Liardo, C; Puzzo, S	1
Amann, K; Hyckel, P; Neukam, F; Nkenke, E; Ries, J; Schlegel, K; Stockmann, P; Wehrhan, F	1
Barrett-Lee, PJ; Bell, R; Brown, J; Burkinshaw, R; Cameron, D; Coleman, R; Davies, C; Dodwell, D; Gil, M; Grieve, RJ; Houston, SJ; Keane, M; Thorpe, H; Woodward, E	1
Burkley, B; Casanova, O; Ferreira, P; Gong, Y; Hou, W; Katz, J; Langaee, TY; Moreb, JS; Salmasinia, D	1
Friedlander, AH	1
Bouganim, N; Clemons, M; Finkelman, RD	1
Aapro, MS	1
Arbitrio, M; Baudi, F; Calimeri, T; Cannataro, M; Cucinotto, I; Di Martino, MT; Guzzi, PH; Leone, E; Piro, E; Prantera, T; Rossi, M; Tagliaferri, P; Tassone, P; Veltri, P	1
Bargagli, G; Francini, E; Francini, F; Miano, ST; Pascucci, A; Petrioli, R; Ruggiero, G	1
Angeli, A; Berruti, A; Bertetto, O; Ciccone, G; Ciuffreda, L; Fusco, V; Galassi, C; Ortega, C	1
Baldwin, CM; D'Silva, NJ; Edwards, PC; Feinberg, SE; Krebsbach, PH; Kuo, S; Scheller, EL	1
Barbounis, V; Boziari, P; Karayianni, A; Kyrtsonis, MC; Migliorati, CA; Nicolatou-Galitis, O; Papadopoulou, E; Repousis, P; Sarri, T	1
Amann, K; Guentsch, A; Neukam, FW; Nkenke, E; Schlegel, KA; Stockmann, P; Wehrhan, F; Wehrhan, T	1
Antoniades, K; Arora, A; Kyrgidis, A	1
Frustino, JL; Kossoff, EB; Ngamphaiboon, N; O'Connor, TL; Sullivan, MA	1
Bartl, R	1
Bonacina, R; Mariani, U; Villa, A; Villa, F	1
Arata, V; Gallesio, G; Mozzati, M	1
Basi, DL; Dudek, AZ; Gopalakrishnan, R; Huckabay, S; Hughes, PJ; Leach, JW; Lunos, S; Swenson, KK; Thumbigere-Math, V; Tu, L	1
Uña, E	1
Marx, RE	1
Csermak, K; Tarassoff, P	1
Carter, GD; Goss, AN	1
Greenberg, MS	1
Bagan, JV; Jimenez-Soriano, Y	1
Crowley, J; Durie, BG; Katz, M	1
Hande, K; Richardson, PG; Woo, SB	1
Duck, L; Maerevoet, M; Martin, C	1
Hellie, CM; Olson, KB; Pienta, KJ	1
Bourgeois, SL; Goodell, GG; Sarathy, AP	1
Broumand, V; Fortin, M; Marx, RE; Sawatari, Y	1
Bagan, JV; Diaz, JM; Hernandez, S; Jimenez, Y; Murillo, J; Poveda, R; Sanchis, JM; Scully, C	1
Gibbs, SD; O'Grady, J; Prince, HM; Seymour, JF	1
Anagnostopoulos, A; Bamia, C; Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Koutsoukou, V; Melakopoulos, I; Moulopoulos, LA; Papadimitriou, C; Terpos, E	1
Abi Najm, S; Carrel, JP; Lesclous, P; Lombardi, T; Lysitsa, S; Samson, J	1
Etayo-Pérez, A; Garatea-Crelgo, J; Martino-Gorbea, R; Pastor-Zuazaga, D; Sebastián-López, C	1
Abu-Id, MH; Açil, Y; Gottschalk, J; Kreusch, T	1
Aglietta, M; Faggiuolo, R; Goia, F; Montemurro, F; Nanni, D; Ortega, C; Vormola, R	1
Alexander, RE	1
Soileau, KM	1
Farrar, SK	1
Englund, K; Hatch, C; Hussein, MA; Isada, C; Karam, MA; Licata, A; Reed, J; Richmond, M; Smith, J; Thakkar, SG; Tomford, JW	1
Dimitrakopoulos, I; Karakasis, D; Magopoulos, C	1
Anagnostopoulos, A; Bamia, C; Bamias, A; Dimopoulos, MA; Gika, D; Kastritis, E; Melakopoulos, I; Moulopoulos, LA; Terpos, E; Tsionos, K	1
Gregersen, H; Neumann, B	1
Biasotto, M; Cavalli, F; Chiandussi, S; Cova, MA; Di Lenarda, R; Dore, F	1
Weeda, LW	1
Kademani, D; Koka, S; Lacy, MQ; Rajkumar, SV	1
Baumann, A; Czerny, C; Eisenmenger, G; Ewers, R; Hoffmann, M; Moser, D; Pietschmann, P; Wutzl, A	1
Doyle-Lindrud, S	1
Aguiar Bujanda, D; Aguiar Morales, J; Bohn Sarmiento, U; Cabrera Suárez, MA	1
Baccarani, M; Brioli, A; Cangini, D; Catalano, L; Cavo, M; Ceccolini, M; Cellini, C; D'Arco, A; Di Raimondo, F; Offidani, M; Perrone, G; Ronconi, S; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E	1
Calvo-Villas, JM; Carreter de Granda, E; Govantes Rodríguez, J; Sicilia Guillén, F; Tapia Torres, M	1
Alati, C; Allegra, A; Alonci, A; Cicciù, M; De Ponte, FS; Musolino, C; Nastro, E; Oteri, G; Quartarone, E	1
Aguiar Bujanda, D; Aguiar Morales, J; Bohn Sarmiento, U; Cabrera Suárez, MA; Quintero Pérez, S	1
Agurto P, J; Anguita C, T; Laissle C, G; Roa E, I	1
Bonaninil, M; Corcione, L; Corradi, D; D'Aleo, P; Ferrari, S; Guidotti, R; Manfredi, M; Meleti, M; Merigo, E; Poli, T; Ripasarti, A; Sesenna, E; Vescovi, P; Zanzucchi, E	1
Agazzi, A; D'Orto, O; Derada Troletti, G; Diego, R; Fontanella, W; Marzano, U; Pagani, D; Pignataro, L	1
Dannemann, C; Grätz, KW; Riener, MO; Zwahlen, RA	1
Anaissie, EJ; Boyette, J; Clarke, BM; Stack, BC; Suen, JY; Vural, E	1
Corso, A; Klersy, C; Lazzarino, M; Mangiacavalli, S; Pica, G; Varettoni, M; Zappasodi, P	1
Arpaci, F; Ataergin, S; Kanat, O; Komurcu, S; Kuzhan, O; Ozet, A; Ozturk, B; Ozturk, M	1
Lipton, A	1
Felicetti, L; Gissi, DB; Marchetti, C; Montebugnoli, L; Pelliccioni, GA; Pizzigallo, A	1
Jawad, AS; Shenker, NG	1
Aglietta, M; Faggiuolo, R; Gilardino, MO; Goia, F; Montemurro, F; Nanni, D; Ortega, C; Vormola, R	1
Ashworth, D; Grew, N; Millar, B; Shetty, S; Srinivasan, D	1
Díaz Rubio, E; García Paredes, B; García Sáenz, JA; López Tarruella, S; Rodríguez Lajusticia, L; Villalobos, L	1
Guthmiller, JM; Humbert, LA; Johnson, GK; Statz, TA	1
Borrás-Blasco, J; Casterá, E; Costa, S; Galan-Brotons, A; Giner-Marco, V; Rosique-Robles, D	1
Casas, N; Delmas, PD; Eriksen, EF; Grbic, JT; Hua, Y; Landesberg, R; Leung, PC; Lin, SQ; Mesenbrink, P; Recknor, CP; Reid, IR	1
Brown, JJ; Ramalingam, L; Zacharin, MR	1
Abu-Id, MH; Acil, Y; Gottschalk, J; Kreusch, T; Russo, PA; Springer, I; Warnke, PH; Wiltfang, J	1
Bedogni, A; Bedogni, G; Blandamura, S; Chiarini, L; Ferrari, F; Ferretti, M; Ferronato, G; Lo Muzio, L; Lo Russo, L; Lokmic, Z; Ninfo, V; Nocini, PF; Palumbo, C; Pietrogrande, F; Procopio, O; Ragazzo, M; Saia, G; Tregnaghi, A	1
Dodson, TB; Wessel, JH; Zavras, AI	1
Altundag, K; Bulut, N; Sari, E	1
Bagan, JV; Gómez, D; Jiménez, Y; Poveda, R; Scully, C; Sirera, R	1
Moore, S; Reilly, MM	1
De Zorzi, Pde M; Lovat, CP; Reiriz, AB	1

Reviews

9 review(s) available for zoledronic acid and Jaw Diseases

Article	Year
Interventions for managing medication-related osteonecrosis of the jaw. The Cochrane database of systematic reviews, 2017, 10-06, Volume: 10 Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Denosumab; Dental Care; Diphosphonates; Female; Humans; Hyperbaric Oxygenation; Imidazoles; Intercellular Signaling Peptides and Proteins; Jaw Diseases; Male; Oral Health; Osteonecrosis; Postoperative Complications; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Tooth Extraction; Zoledronic Acid	2017
Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head and neck pathology, 2007, Volume: 1, Issue:2 Topics: Administration, Oral; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Mandible; Osteonecrosis; Pamidronate; Retrospective Studies; Zoledronic Acid	2007
Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report. Head and neck pathology, 2007, Volume: 1, Issue:2 Topics: Aged; Bone Density Conservation Agents; Contraindications; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2007
Osteonecrosis of the jaw and the role of macrophages. Journal of the National Cancer Institute, 2011, Feb-02, Volume: 103, Issue:3 Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Indoles; Jaw Diseases; Macrophages; Magnetic Resonance Imaging; Mevalonic Acid; Monocytes; Mouth Mucosa; Osteoclasts; Osteomyelitis; Osteonecrosis; Positron-Emission Tomography; Pyrroles; Radiography, Panoramic; RANK Ligand; Risedronic Acid; Risk Factors; Signal Transduction; Sunitinib; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid	2011
Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid. Urology, 2005, Volume: 66, Issue:3 Topics: Adenocarcinoma; Androgen Antagonists; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Prostatic Neoplasms; Treatment Failure; Zoledronic Acid	2005
Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral oncology, 2006, Volume: 42, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Tooth Extraction; Zoledronic Acid	2006
[Bisphosphonate-associated osteonecrosis of the jaw]. Mund-, Kiefer- und Gesichtschirurgie : MKG, 2006, Volume: 10, Issue:2 Topics: Aged; Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Mandible; Maxilla; Middle Aged; Neoplasms; Osteoporosis; Pamidronate; Risk Factors; Zoledronic Acid	2006
Implications of androgen-deprivation therapy in patients with prostate cancer: A case study. Clinical journal of oncology nursing, 2006, Volume: 10, Issue:5 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Combined Modality Therapy; Diphosphonates; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Jaw Diseases; Leuprolide; Male; Orchiectomy; Osteonecrosis; Osteoporosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Risk Factors; Tomography, X-Ray Computed; Zoledronic Acid	2006
The safety of zoledronic acid. Expert opinion on drug safety, 2007, Volume: 6, Issue:3 Topics: Antineoplastic Agents; Clinical Trials as Topic; Creatinine; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Kidney; Osteonecrosis; Product Surveillance, Postmarketing; Zoledronic Acid	2007

Trials

10 trial(s) available for zoledronic acid and Jaw Diseases

Article	Year
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-20, Volume: 31, Issue:21 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Middle Aged; Oral Health; Osteonecrosis; Quality of Life; Zoledronic Acid	2013
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clinical oral investigations, 2010, Volume: 14, Issue:3 Topics: Aged; Bone Density Conservation Agents; Bone Marrow; Contrast Media; Diphosphonates; Female; Follow-Up Studies; Gadolinium; Humans; Imidazoles; Jaw Diseases; Magnetic Resonance Imaging; Male; Mandibular Diseases; Maxillary Diseases; Organometallic Compounds; Osteolysis; Osteonecrosis; Pamidronate; Radiography, Panoramic; Tomography, X-Ray Computed; Zoledronic Acid	2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results. Clinical breast cancer, 2010, Volume: 10, Issue:1 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Middle Aged; Osteonecrosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Zoledronic Acid	2010
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. Journal of the American Dental Association (1939), 2010, Volume: 141, Issue:11 Topics: Biomarkers; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Collagen Type I; Databases as Topic; Diphosphonates; Female; Follow-Up Studies; Forecasting; Humans; Imidazoles; Incidence; Jaw Diseases; Male; Osteonecrosis; Osteoporosis, Postmenopausal; Peptides; Placebos; Prevalence; Risk Factors; United States; Zoledronic Acid	2010
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast cancer research and treatment, 2011, Volume: 127, Issue:2 Topics: Adult; Aged; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Imidazoles; Incidence; Jaw Diseases; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Osteonecrosis; Treatment Outcome; Zoledronic Acid	2011
Tooth extraction in patients on zoledronic acid therapy. Oral oncology, 2012, Volume: 48, Issue:9 Topics: Case-Control Studies; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Radiography, Panoramic; Tomography, X-Ray Computed; Tooth Extraction; Zoledronic Acid	2012
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica, 2006, Volume: 91, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Risk; Time Factors; Zoledronic Acid	2006
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone. Blood, 2006, Dec-01, Volume: 108, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Retrospective Studies; Thalidomide; Zoledronic Acid	2006
Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 104, Issue:4 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Linear Models; Male; Metronidazole; Middle Aged; Osteonecrosis; Pamidronate; Prospective Studies; Zoledronic Acid	2007
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. Journal of the American Dental Association (1939), 2008, Volume: 139, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Epidemiologic Methods; Female; Hip Fractures; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteitis; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Periapical Abscess; Zoledronic Acid	2008

Other Studies

124 other study(ies) available for zoledronic acid and Jaw Diseases

Article	Year
Effects of Soft Tissue Closure on Medication-Related Osteonecrosis of the Jaw in a Rabbit Model with Tooth Extraction: A Pilot Study. BioMed research international, 2021, Volume: 2021 Topics: Animals; Bicuspid; Bone Density; Female; Jaw Diseases; Mandible; Models, Animal; Osteonecrosis; Pilot Projects; Rabbits; Tooth; Tooth Extraction; Tooth Socket; Zoledronic Acid	2021
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:2 Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Cell Differentiation; Dendritic Cells; Homeostasis; Imidazoles; Jaw Diseases; Osteoclasts; Osteonecrosis; Tooth Extraction; Wound Healing; Zoledronic Acid	2020
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing. Oral and maxillofacial surgery, 2022, Volume: 26, Issue:2 Topics: Acyclic Monoterpenes; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Endothelial Cells; Humans; Ibandronic Acid; Jaw Diseases; Mouth Diseases; Osteonecrosis; Wound Healing; Zoledronic Acid	2022
Influence of Japanese Regulatory Action on Denosumab-Related Hypocalcemia Using Japanese Adverse Drug Event Report Database. Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:9 Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Asian People; Bone Density Conservation Agents; Databases, Factual; Denosumab; Diphosphonates; Humans; Hypocalcemia; Imidazoles; Japan; Jaw Diseases; Logistic Models; Odds Ratio; Osteonecrosis; Zoledronic Acid	2017
Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral surgery, oral medicine, oral pathology and oral radiology, 2018, Volume: 125, Issue:5 Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Incidence; Indoles; Ipilimumab; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Pamidronate; Pyrroles; Retrospective Studies; Sunitinib; Zoledronic Acid	2018
The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. International journal of oral and maxillofacial surgery, 2013, Volume: 42, Issue:11 Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Jaw Diseases; Mandible; Osteogenesis; Osteoporosis; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Tooth Extraction; Zoledronic Acid	2013
Bisphosphonate-related osteonecrosis of jaw in the adjuvant breast cancer setting: risks and perspective. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-20, Volume: 31, Issue:21 Topics: Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2013
Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates. The British journal of oral & maxillofacial surgery, 2014, Volume: 52, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Carcinoma; Denosumab; Diphosphonates; Female; Femur; Frontal Bone; Humans; Image Processing, Computer-Assisted; Imidazoles; Jaw Diseases; Mandible; Maxilla; Middle Aged; Osteonecrosis; Radionuclide Imaging; RANK Ligand; Retrospective Studies; Zoledronic Acid	2014
Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients. Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:4 Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease-Free Survival; Female; Germany; Hematologic Neoplasms; Humans; Ibandronic Acid; Imidazoles; Jaw Diseases; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Osteonecrosis; Pamidronate; Prostatic Neoplasms; Registries; Risk Factors; Sex Factors; Time Factors; Zoledronic Acid	2015
Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw. Clinical oral investigations, 2016, Volume: 20, Issue:8 Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Jaw Diseases; Microscopy, Electron, Scanning; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Zoledronic Acid	2016
Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2008, Volume: 66, Issue:7 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Mandible; Middle Aged; Osteonecrosis; Zoledronic Acid	2008
Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Oct-01, Volume: 26, Issue:28 Topics: Adult; Aged; Bone Density Conservation Agents; Breast Neoplasms; Case-Control Studies; Chi-Square Distribution; Dental Care for Chronically Ill; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Logistic Models; Middle Aged; Osteonecrosis; Retrospective Studies; Risk Factors; Zoledronic Acid	2008
Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. European urology, 2008, Volume: 54, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Cross-Sectional Studies; Diphosphonates; Follow-Up Studies; Germany; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Prevalence; Prognosis; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Zoledronic Acid	2008
Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management. Quintessence international (Berlin, Germany : 1985), 2008, Volume: 39, Issue:3 Topics: Aged; Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Hyperbaric Oxygenation; Imidazoles; Jaw Diseases; Osteonecrosis; Osteoporosis; Tooth Extraction; Zoledronic Acid	2008
Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:1 Topics: Academies and Institutes; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Dental Prophylaxis; Diphosphonates; Female; Humans; Imidazoles; Incidence; Italy; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Retrospective Studies; Young Adult; Zoledronic Acid	2009
Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:11 Topics: Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Health Knowledge, Attitudes, Practice; Humans; Imidazoles; Incidence; Italy; Jaw Diseases; Male; Osteonecrosis; Pamidronate; Retrospective Studies; Risk Factors; Zoledronic Acid	2008
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Dental Prophylaxis; Diphosphonates; Female; Humans; Imidazoles; Incidence; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pyrazines; Retrospective Studies; Thalidomide; Young Adult; Zoledronic Acid	2009
Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral oncology, 2009, Volume: 45, Issue:2 Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Diseases, Metabolic; Dexamethasone; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Injections, Intravenous; Jaw Diseases; Mandibular Diseases; Maxillary Diseases; Oral Ulcer; Osteonecrosis; Prospective Studies; Rats; Rats, Sprague-Dawley; Zoledronic Acid	2009
Re: Christian Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72. European urology, 2009, Volume: 55, Issue:4 Topics: Bone Density Conservation Agents; Diphosphonates; Disease Progression; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Prevalence; Prostatic Neoplasms; Risk Factors; Zoledronic Acid	2009
Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 106, Issue:6 Topics: Aged; Aged, 80 and over; Alveolar Bone Loss; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; DMF Index; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Periodontal Index; Pilot Projects; Retrospective Studies; Risk Factors; Stomatitis, Denture; Tooth Extraction; Zoledronic Acid	2008
Re: Christan Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72. European urology, 2009, Volume: 55, Issue:3 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Prevalence; Prostatic Neoplasms; Risk Factors; Zoledronic Acid	2009
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. British journal of haematology, 2009, Volume: 144, Issue:5 Topics: Apoptosis; Blotting, Western; Bone Density Conservation Agents; Caspase 3; Caspase 9; Cell Line; Cell Proliferation; Diphosphonates; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Gene Expression; Gene Expression Profiling; Gingiva; Humans; Imidazoles; In Situ Nick-End Labeling; Jaw Diseases; Mouth Mucosa; Oligonucleotide Array Sequence Analysis; Osteonecrosis; RNA Interference; RNA, Small Interfering; Zoledronic Acid	2009
Comment on: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral oncology, 2009, Volume: 45, Issue:6 Topics: Animals; Apoptosis; Bone Density Conservation Agents; Breast Neoplasms; Dexamethasone; Diphosphonates; Disease Models, Animal; Female; Glucocorticoids; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Rats; Tooth Extraction; Zoledronic Acid	2009
Clinical characterization might help in preventing osteonecrosis of the jaw. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-15, Volume: 14, Issue:24 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2008
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:3 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Zoledronic Acid	2009
Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series. The Laryngoscope, 2009, Volume: 119, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Belgium; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Retrospective Studies; Risk Factors; Zoledronic Acid	2009
Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile? Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:3 Topics: Angiogenesis Inhibitors; Diphosphonates; Humans; Imidazoles; Indoles; Jaw Diseases; Osteonecrosis; Pyrroles; Sunitinib; Zoledronic Acid	2009
Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach. Head & neck, 2009, Volume: 31, Issue:9 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2009
Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases. JOP : Journal of the pancreas, 2009, Mar-09, Volume: 10, Issue:2 Topics: Adenocarcinoma; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Neoplasm Staging; Osteonecrosis; Pancreatic Neoplasms; Zoledronic Acid	2009
Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Minimally Invasive Surgical Procedures; Oral Surgical Procedures; Osteonecrosis; Pamidronate; Risk Factors; Smoking; Time Factors; Treatment Outcome; Wound Healing; Zoledronic Acid	2009
Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pamidronate; Treatment Outcome; Zoledronic Acid	2009
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:7 Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphosphonates; Early Diagnosis; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Pamidronate; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Compounds; Zoledronic Acid	2009
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clinical oral investigations, 2010, Volume: 14, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid	2010
Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-10, Volume: 27, Issue:32 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Greece; Humans; Ibandronic Acid; Imidazoles; Incidence; Jaw Diseases; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Prostatic Neoplasms; Risk Factors; Zoledronic Acid	2009
Bisphosphonate-related osteonecrosis of the jaw and left thumb. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-10, Volume: 27, Issue:35 Topics: Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Curettage; Diphosphonates; Female; Finger Phalanges; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteonecrosis; Osteotomy; Radiography; Thumb; Zoledronic Acid	2009
Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. Journal of bone and mineral metabolism, 2010, Volume: 28, Issue:2 Topics: Animals; Bacterial Adhesion; Bacterial Physiological Phenomena; Bone Density Conservation Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Dental Plaque; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Jaw Diseases; Male; Mice; Mice, Inbred Strains; Mouth Mucosa; Neovascularization, Physiologic; Osteogenesis; Osteonecrosis; Streptococcus mutans; Tooth Extraction; Tooth Socket; Wound Healing; Zoledronic Acid	2010
Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer. Cancer investigation, 2009, Volume: 27, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Fractures, Bone; Humans; Imidazoles; Jaw Diseases; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Prostatic Neoplasms; Retrospective Studies; Spinal Cord Compression; Time Factors; Treatment Outcome; Zoledronic Acid	2009
Scintigraphic evaluation of mandibular bone turnover in patients with solid tumors receiving zoledronic acid. Oral oncology, 2010, Volume: 46, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Risk Factors; Tomography, Emission-Computed; Zoledronic Acid	2010
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:6 Topics: Animals; Apoptosis; Diphosphonates; Disease Models, Animal; Femur; Gene Expression Regulation; Humans; Imidazoles; Inflammation; Jaw Diseases; Oligonucleotide Array Sequence Analysis; Osteoclasts; Osteogenesis; Osteonecrosis; Rats; Rats, Sprague-Dawley; Tooth Extraction; Vitamin D; Vitamin D Deficiency; Zoledronic Acid	2010
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:7 Topics: Animals; Cytokines; Dexamethasone; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Immunosuppressive Agents; Immunotherapy; Jaw Diseases; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred C57BL; Mice, Nude; Osteonecrosis; T-Lymphocytes, Regulatory; Zoledronic Acid	2010
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2010, Volume: 39, Issue:5 Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Injections, Intravenous; Jaw Diseases; Maxillary Diseases; Osteonecrosis; Radionuclide Imaging; Rats; Rats, Wistar; Reproducibility of Results; Tooth Extraction; Zoledronic Acid	2010
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2010, Volume: 110, Issue:1 Topics: Aged; Alcohol Drinking; Alendronate; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic Disease; Clindamycin; Cohort Studies; Combined Modality Therapy; Debridement; Diphosphonates; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Imidazoles; Jaw Diseases; Male; Oral Fistula; Osteonecrosis; Pamidronate; Penicillins; Prospective Studies; Remission Induction; Risk Factors; Smoking; Tooth Extraction; Treatment Outcome; Wound Healing; Zoledronic Acid	2010
Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:2 Topics: Animals; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Dogs; Female; Imidazoles; Jaw Diseases; Osteonecrosis; Tomography, X-Ray Computed; Tooth Extraction; Treatment Outcome; Wound Healing; Zoledronic Acid	2011
Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. The American journal of pathology, 2010, Volume: 177, Issue:1 Topics: Animals; Antineoplastic Agents; Bone Density Conservation Agents; Bone Remodeling; Dexamethasone; Diphosphonates; Docetaxel; Humans; Imidazoles; Jaw Diseases; Mandible; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Osteocytes; Osteonecrosis; Taxoids; Zoledronic Acid	2010
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:11 Topics: Bone Density Conservation Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Ibandronic Acid; Imidazoles; Jaw Diseases; Mesenchymal Stem Cells; Osteonecrosis; Time Factors; Zoledronic Acid	2010
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:1 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Debridement; Diphosphonates; Doxycycline; Female; Fluorescence; Fluorescent Dyes; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pilot Projects; Prospective Studies; Surgical Flaps; Surgical Wound Dehiscence; Treatment Outcome; Wound Healing; Zoledronic Acid	2011
Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2010, Volume: 110, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Laser Therapy; Lasers, Solid-State; Low-Level Light Therapy; Mandibular Diseases; Middle Aged; Osteonecrosis; Photochemotherapy; Surgical Wound Dehiscence; Wound Healing; Zoledronic Acid	2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid. American journal of hematology, 2011, Volume: 86, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Kidney Diseases; Male; Middle Aged; Multiple Myeloma; Prognosis; Retrospective Studies; Risk Factors; Zoledronic Acid	2011
Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Archives of oral biology, 2011, Volume: 56, Issue:5 Topics: Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Collagen; Diphosphonates; Down-Regulation; Epithelial Cells; Fibroblasts; Humans; Imidazoles; Jaw Diseases; Mouth Mucosa; Osteonecrosis; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tooth Extraction; Wound Healing; Zoledronic Acid	2011
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. Frontiers in bioscience (Elite edition), 2011, 01-01, Volume: 3, Issue:1 Topics: Bone Density Conservation Agents; Diphosphonates; Female; Gene Frequency; Genetic Predisposition to Disease; Geranyltranstransferase; Humans; Imidazoles; Italy; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Pharmacogenetics; Polymorphism, Single Nucleotide; Retrospective Studies; White People; Zoledronic Acid	2011
Rubber dam clamp trauma during endodontic treatment: a risk factor of bisphosphonate-related osteonecrosis of the jaw? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:6 Topics: Bone Density Conservation Agents; Dental Caries; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteonecrosis; Risk Factors; Root Canal Therapy; Rubber Dams; Zoledronic Acid	2011
Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2011, Volume: 40, Issue:6 Topics: Bone Density Conservation Agents; Breast Neoplasms; Case-Control Studies; Chi-Square Distribution; Diphosphonates; Female; Haplotypes; Humans; Imidazoles; Jaw Diseases; Multiple Myeloma; Odds Ratio; Osteonecrosis; Polymorphism, Single Nucleotide; Vascular Endothelial Growth Factor A; Zoledronic Acid	2011
Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral oncology, 2011, Volume: 47, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Italy; Jaw Diseases; Male; Middle Aged; Orthognathic Surgical Procedures; Osteonecrosis; Retrospective Studies; Risk Factors; Zoledronic Acid	2011
Preventive protocol for tooth extractions in patients treated with zoledronate: a case series. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:6 Topics: Antibiotic Prophylaxis; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteonecrosis; Radiography, Panoramic; Tooth Extraction; Zoledronic Acid	2011
Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment. Oral diseases, 2011, Volume: 17, Issue:4 Topics: Alkaline Phosphatase; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Remodeling; Cell Count; Diphosphonates; Fibroblasts; Humans; Imidazoles; Immunohistochemistry; Jaw Diseases; MSX1 Transcription Factor; Osteoblasts; Osteocytes; Osteonecrosis; Osteopetrosis; Pamidronate; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Zoledronic Acid	2011
Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. International journal of oral and maxillofacial surgery, 2011, Volume: 40, Issue:6 Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Bone Density Conservation Agents; Cohort Studies; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytochrome P-450 CYP2C8; Diphosphonates; Female; Gene Frequency; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Matrix Metalloproteinase 2; Middle Aged; Multiple Myeloma; Osteonecrosis; Osteopontin; Osteoprotegerin; Pamidronate; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptor Activator of Nuclear Factor-kappa B; Risk Factors; Smoking; Time Factors; Tumor Necrosis Factor-alpha; Zoledronic Acid	2011
Osteonecrosis of the jaw. Journal of the American Dental Association (1939), 2011, Volume: 142, Issue:4 Topics: Biomarkers; Bone Density Conservation Agents; Collagen Type I; Dental Care; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Peptides; Risk Factors; Zoledronic Acid	2011
More about osteonecrosis. Journal of the American Dental Association (1939), 2011, Volume: 142, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Density Conservation Agents; Denosumab; Dental Care; Diphosphonates; Drug Interactions; Humans; Imidazoles; Jaw Diseases; Oral Hygiene; Osteonecrosis; RANK Ligand; Risk Factors; Zoledronic Acid	2011
Denosumab for bone metastases from breast cancer: a new therapy option? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, May-10, Volume: 29, Issue:14 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Kidney; Osteonecrosis; RANK Ligand; Zoledronic Acid	2011
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling. British journal of haematology, 2011, Volume: 154, Issue:4 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Gene Frequency; Genetic Predisposition to Disease; Humans; Imidazoles; Jaw Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Polymorphism, Single Nucleotide; PPAR gamma; Zoledronic Acid	2011
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab. Journal of the American Dental Association (1939), 2011, Volume: 142, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Collagen Type I; Dental Care; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Lung Neoplasms; Male; Middle Aged; Osteonecrosis; Peptides; Periodontal Diseases; Radiography, Panoramic; Risk Factors; Tooth Extraction; Zoledronic Acid	2011
Osteonecrosis of the jaw after zoledronic acid and denosumab treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-10, Volume: 29, Issue:17 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Humans; Imidazoles; Incidence; Jaw Diseases; Osteonecrosis; RANK Ligand; Zoledronic Acid	2011
Bisphosphonates inhibit expression of p63 by oral keratinocytes. Journal of dental research, 2011, Volume: 90, Issue:7 Topics: Adult Stem Cells; Analysis of Variance; Bone Density Conservation Agents; Case-Control Studies; Cell Line, Transformed; Diphosphonates; Gene Expression; Gene Knockdown Techniques; Humans; Imidazoles; Jaw Diseases; Keratinocytes; Membrane Proteins; Mevalonic Acid; Osteonecrosis; RNA, Small Interfering; Tissue Culture Techniques; Wound Healing; Zoledronic Acid	2011
Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 112, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Cariostatic Agents; Chlorhexidine; Dental Prophylaxis; Diphosphonates; Female; Fluorides; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Longitudinal Studies; Male; Middle Aged; Neoplasms; Oral Hygiene; Osteonecrosis; Pain Measurement; Pamidronate; Prospective Studies; Treatment Outcome; Zoledronic Acid	2011
Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 112, Issue:2 Topics: Alkaline Phosphatase; Alveolar Process; Antigens, CD; Bone Density Conservation Agents; Capillaries; Coloring Agents; Connective Tissue; Diphosphonates; Endoglin; Endothelial Cells; Endothelium, Vascular; Humans; Image Processing, Computer-Assisted; Imidazoles; Immunohistochemistry; Jaw Diseases; Mouth Mucosa; Neovascularization, Physiologic; Osteonecrosis; Periosteum; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Cell Surface; Zoledronic Acid	2011
Rubber dam clamp trauma, root canal therapy, and osteonecrosis of the jaw. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:7 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Root Canal Therapy; Rubber Dams; Zoledronic Acid	2011
Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab. Clinical breast cancer, 2011, Volume: 11, Issue:4 Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Middle Aged; Neoplasm Metastasis; Osteonecrosis; Pamidronate; Retrospective Studies; Survival Rate; Treatment Outcome; Zoledronic Acid	2011
[Inflammation of the jaws during treatment with bisphosphonates]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:41 Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Drug Approval; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Opportunistic Infections; Osteomyelitis; Osteonecrosis; Osteoporosis; Pamidronate; Practice Guidelines as Topic; Risk Factors; Zoledronic Acid	2011
Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. Journal (Canadian Dental Association), 2011, Volume: 77 Topics: Adult; Aged; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Risk Factors; Zoledronic Acid	2011
A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates. American journal of clinical oncology, 2012, Volume: 35, Issue:4 Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Incidence; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Neoplasm Staging; Neoplasms; Osteonecrosis; Pamidronate; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Zoledronic Acid	2012
Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates. BMJ case reports, 2012, Mar-27, Volume: 2012 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2012
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2003, Volume: 61, Issue:9 Topics: Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteoclasts; Osteocytes; Osteonecrosis; Pamidronate; Zoledronic Acid	2003
Avascular necrosis of the jaws: risk factors in metastatic cancer patients. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2003, Volume: 61, Issue:10 Topics: Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Pamidronate; Risk Factors; Zoledronic Acid	2003
Bisphosphonates and avascular necrosis of the jaws. Australian dental journal, 2003, Volume: 48, Issue:4 Topics: Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Pamidronate; Tooth Extraction; Zoledronic Acid	2003
Intravenous bisphosphonates and osteonecrosis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2004, Volume: 98, Issue:3 Topics: Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Interdisciplinary Communication; Jaw Diseases; Osteolysis; Osteonecrosis; Pamidronate; Zoledronic Acid	2004
[Rapid drug information]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2005, Volume: 48, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Information Services; Germany; Humans; Imidazoles; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Osteoporosis; Pamidronate; Risk Assessment; Zoledronic Acid	2005
Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update. Medicina oral, patologia oral y cirugia bucal, 2005, Jul-01, Volume: 10 Suppl 2 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Osteonecrosis; Osteoporosis; Pamidronate; Zoledronic Acid	2005
Osteonecrosis of the jaw and bisphosphonates. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Breast Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Pamidronate; Risk Factors; Zoledronic Acid	2005
Osteonecrosis of the jaw and bisphosphonates. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Alendronate; Animals; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Osteoporosis; Pamidronate; Zoledronic Acid	2005
Osteonecrosis of the jaw and bisphosphonates. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Breast Neoplasms; Dental Care; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Risk Factors; Zoledronic Acid	2005
Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports. Journal of endodontics, 2005, Volume: 31, Issue:10 Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Pamidronate; Zoledronic Acid	2005
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2005, Volume: 63, Issue:11 Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Dental Caries; Dexamethasone; Diphosphonates; Drug Interactions; Female; Humans; Hyperostosis; Imidazoles; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Osteopetrosis; Osteoporosis; Pamidronate; Periodontitis; Prostatic Neoplasms; Risk Factors; Tooth Extraction; Zoledronic Acid	2005
Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention. The Medical journal of Australia, 2005, Nov-21, Volume: 183, Issue:10 Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Time Factors; Tooth Extraction; Zoledronic Acid	2005
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Greece; Humans; Imidazoles; Incidence; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors; Treatment Failure; Zoledronic Acid	2005
[Bisphosphonates-related jaw osteonecrosis]. Presse medicale (Paris, France : 1983), 2005, Sep-10, Volume: 34, Issue:15 Topics: Adolescent; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pamidronate; Radiography, Panoramic; Radionuclide Imaging; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid	2005
Osteonecrosis of the jaws and bisphosphonates. Report of three cases. Medicina oral, patologia oral y cirugia bucal, 2006, Jan-01, Volume: 11, Issue:1 Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Tooth Extraction; Zoledronic Acid	2006
Jaw complications in breast and prostate cancer patients treated with zoledronic acid. Acta oncologica (Stockholm, Sweden), 2006, Volume: 45, Issue:2 Topics: Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Prostatic Neoplasms; Zoledronic Acid	2006
Relationship between periodontal disease and systemic diseases. Texas dental journal, 2006, Volume: 123, Issue:2 Topics: Alendronate; Bone Density Conservation Agents; Contraindications; Dental Implantation, Endosseous; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Osteonecrosis; Pamidronate; Zoledronic Acid	2006
Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy. Journal of periodontology, 2006, Volume: 77, Issue:4 Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Periodontitis; Zoledronic Acid	2006
Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. LDA journal, 2005,Fall, Volume: 64, Issue:3 Topics: Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Zoledronic Acid	2005
The buzz about bisphosphonates. LDA journal, 2005,Fall, Volume: 64, Issue:3 Topics: Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Pamidronate; Zoledronic Acid	2005
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias. Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Paraproteinemias; Zoledronic Acid	2006
Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. International journal of oral and maxillofacial surgery, 2006, Volume: 35, Issue:7 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Retrospective Studies; Tooth Extraction; Zoledronic Acid	2006
[Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis]. Ugeskrift for laeger, 2006, May-22, Volume: 168, Issue:21 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Pamidronate; Zoledronic Acid	2006
Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dento maxillo facial radiology, 2006, Volume: 35, Issue:4 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Radiography, Panoramic; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Zoledronic Acid	2006
Drug induced osteonecrosis of the jaws. The Journal of the Tennessee Dental Association, 2006,Spring, Volume: 86, Issue:2 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Osteoclasts; Osteomyelitis; Osteonecrosis; Pamidronate; Splints; Zoledronic Acid	2006
Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clinic proceedings, 2006, Volume: 81, Issue:8 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Oral Surgical Procedures; Osteonecrosis; Osteoporosis; Pamidronate; Zoledronic Acid	2006
Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:15-16 Topics: Adult; Aged; Biopsy; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Magnetic Resonance Imaging; Male; Mandible; Mandibular Diseases; Maxilla; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Radiography, Panoramic; Radionuclide Imaging; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid	2006
Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Creatinine; Diphosphonates; Drug Monitoring; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Kidney Diseases; Male; Middle Aged; Osteonecrosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Zoledronic Acid	2007
[Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid]. Medicina clinica, 2006, Oct-21, Volume: 127, Issue:15 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Incidence; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Risk Factors; Zoledronic Acid	2006
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. Acta haematologica, 2007, Volume: 117, Issue:3 Topics: Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Mandible; Maxilla; Middle Aged; Multiple Myeloma; Necrosis; Osteonecrosis; Pamidronate; Tomography, X-Ray Computed; Zoledronic Acid	2007
Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Mastectomy; Middle Aged; Osteonecrosis; Radiotherapy; Zoledronic Acid	2006
[Osteonecrosis associated with the use of biphosphonates: Case report]. Revista medica de Chile, 2006, Volume: 134, Issue:9 Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis; Pamidronate; Zoledronic Acid	2006
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta bio-medica : Atenei Parmensis, 2006, Volume: 77, Issue:2 Topics: Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antifungal Agents; Bone Density Conservation Agents; Bone Neoplasms; Chlorhexidine; Curettage; Diphosphonates; Female; Humans; Hydrogen Peroxide; Imidazoles; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Mouthwashes; Multiple Myeloma; Osteonecrosis; Osteoporosis; Pamidronate; Radiography; Time Factors; Zoledronic Acid	2006
Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:3 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Zoledronic Acid	2007
I'm taking bisphosphonates for my osteoporosis, but I've heard it can cause a serious jaw condition. Is this something I should be concerned about? DukeMedicine healthnews, 2006, Volume: 12, Issue:11 Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Pamidronate; Zoledronic Acid	2006
Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone, 2007, Volume: 40, Issue:4 Topics: Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pamidronate; Risk Factors; Switzerland; Time Factors; Zoledronic Acid	2007
Bisphosphonates and jaw osteonecrosis: the UAMS experience. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2007, Volume: 136, Issue:3 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bone Density Conservation Agents; Curettage; Dental Care; Diphosphonates; Female; Humans; Hyperbaric Oxygenation; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Retrospective Studies; Time Factors; Treatment Outcome; Zoledronic Acid	2007
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. Leukemia, 2007, Volume: 21, Issue:7 Topics: Aged; Diphosphonates; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imidazoles; Incidence; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Retrospective Studies; Risk Factors; Zoledronic Acid	2007
Bisphosphonate treatment as a cause of jaw osteonecrosis. Oral diseases, 2007, Volume: 13, Issue:3 Topics: Anti-Bacterial Agents; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Tooth Extraction; Zoledronic Acid	2007
Bisphosphonates and osteonecrosis of the jaw. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:7 Topics: Bone Remodeling; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Neoplasms; Osteonecrosis; Osteoporosis; Pamidronate; Zoledronic Acid	2007
Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:5 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Prostatic Neoplasms; Zoledronic Acid	2007
Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws. British dental journal, 2007, Jul-28, Volume: 203, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Chlorhexidine; Diphosphonates; Facial Pain; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Osteoporosis, Postmenopausal; Tetracycline; Zoledronic Acid	2007
Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid. Medicina oral, patologia oral y cirugia bucal, 2007, Sep-01, Volume: 12, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Prostatic Neoplasms; Zoledronic Acid	2007
Intravenous bisphosphonate-associated osteonecrosis of the jaw. Journal of periodontology, 2007, Volume: 78, Issue:11 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Mandibular Fractures; Multiple Myeloma; Osteonecrosis; Radiography; Zoledronic Acid	2007
Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid. Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:6 Topics: Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Time Factors; Zoledronic Acid	2007
Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Clinical endocrinology, 2008, Volume: 68, Issue:6 Topics: Adolescent; Bone Density Conservation Agents; Child; Cohort Studies; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Oral Surgical Procedures; Osteonecrosis; Pamidronate; Zoledronic Acid	2008
"Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2008, Volume: 36, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Neoplasms; Oral Surgical Procedures; Osteonecrosis; Pamidronate; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Zoledronic Acid	2008
Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 105, Issue:3 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw; Jaw Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Tomography, Spiral Computed; Tooth Extraction; Water; Zoledronic Acid	2008
Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2008, Volume: 66, Issue:4 Topics: Age Factors; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Case-Control Studies; Confounding Factors, Epidemiologic; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Logistic Models; Male; Multivariate Analysis; Neoplasms; Obesity; Osteonecrosis; Pamidronate; Risk Factors; Smoking; Zoledronic Acid	2008
Osteonecrosis of the jaw. Journal of the American Dental Association (1939), 2008, Volume: 139, Issue:4 Topics: Bone Density Conservation Agents; Diphosphonates; Female; Hip Fractures; Humans; Imidazoles; Jaw Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Pamidronate; Time Factors; Zoledronic Acid	2008
Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates. Oral oncology, 2008, Volume: 44, Issue:11 Topics: Aged; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Case-Control Studies; Collagen Type I; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Zoledronic Acid	2008
Osteonecrosis of the jaw. Oncology (Williston Park, N.Y.), 2008, Volume: 22, Issue:2 Suppl Nu Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteonecrosis; Penicillin V; Risk Factors; Tooth Extraction; Zoledronic Acid	2008
Bisphosphonates and osteonecrosis of the jaw: a case report. Clinics (Sao Paulo, Brazil), 2008, Volume: 63, Issue:2 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Zoledronic Acid	2008